Xibrom Related Clinical Trials
Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers [Recruiting]
A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease [Not yet recruiting]
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy [Recruiting]
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-Operative Cystoid Macular Edema. [Active, not recruiting]
Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care [Recruiting]
Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery [Recruiting]
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT) [Not yet recruiting]
Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser [Recruiting]
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects [Completed]
Combination Ranibizumab and Bromfenac for Neovascular Age-Related Macular Degeneration [Recruiting]
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening [Recruiting]
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease [Recruiting]
Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. [Recruiting]
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [Active, not recruiting]
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery [Active, not recruiting]
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery [Completed]
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase [Recruiting]
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery [Recruiting]
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification [Recruiting]
PRevention of Macular EDema After Cataract Surgery [Not yet recruiting]
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients [Completed]
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas [Recruiting]
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas [Recruiting]
Efficacy and Safety of Bromfenac Ophthalmic Solution [Recruiting]
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery [Recruiting]
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery [Recruiting]
Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% [Recruiting]
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1% [Recruiting]
Comparative Study to Evaluate ISV-305 Compared to Vehicle in Non-Bacterial Blepharitis Subjects [Not yet recruiting]
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2) [Recruiting]
|
